Question

A 61-year-old with T2DM and A1c 9.2% is on metformin and basal insulin. CKD stage 3a (eGFR 52). Which non-insulin agent has proven CV and renal benefits and is appropriate?

Accepted Answer

Add SGLT2 inhibitor if eGFR ≥20 mL/min/1.73 m²

Answer

Add sulfonylurea as first choice

Answer

Add DPP-4 inhibitor for CV benefit

Answer

Avoid SGLT2 inhibitors due to CKD

Answer

Use thiazolidinedione as preferred

Practice question

A 61-year-old with T2DM and A1c 9.2% is on metformin and basal insulin. CKD stage 3a (eGFR 52). Which non-insulin agent has proven CV and renal benefits and is appropriate?